Dr. Jeffrey J. Raizer

Dr. Jeffrey J. Raizer is a board-certified neuro-oncologist whose career has been anchored at Northwestern Medicine’s Lou and Jean Malnati Brain Tumor Institute, where he guides medical neuro-oncology and holds an adjunct professorship in neurology at the Feinberg School of Medicine. His academic path began with medical studies at New York Medical College, advanced through neurology residencies at NYU and Yale, and culminated in fellowship training in neuro-oncology at Memorial Sloan Kettering Cancer Center, experiences that fused neurologic finesse with systematic cancer therapeutics. These appointments established a clinician-scientist equally versed in neurologic examination and oncology trial design. 

 

Within the clinic Dr. Raizer allocates generous time for history taking, neurologic mapping, and shared decision-making that respects individual goals, family dynamics, and logistical challenges. He explains imaging findings with annotated scans, outlines pharmacologic choices in plain language, and coordinates supportive resources such as physical therapy and cognitive rehabilitation. Long-standing collaborations with neurosurgery, radiation oncology, and neuropathology streamline transitions from biopsy to systemic therapy, while secure telehealth portals keep geographically distant families informed without travel burdens. Patient-reported outcome tools allow early detection of fatigue, cognition changes, or seizure triggers so therapy can be adjusted before quality of life erodes.

 

Research remains central to his practice. Dr. Raizer serves as site investigator on multicenter trials evaluating CSF1R blockade, FGFR inhibition, and Tumor Treating Fields integration with systemic agents, and he mentors fellows in adaptive-design methodology and neurologic toxicity grading. Publications in Neuro-Oncology Advances and Clinical Cancer Research document his contributions to targeted therapy, leptomeningeal disease, and quality-of-life science, while qualitative studies explore patient choices around wearable electric-field therapy. Professional memberships in the Society for Neuro-Oncology, American Academy of Neurology, and American Society of Clinical Oncology keep him engaged with guideline development and peer review.